All News

After the failed merger, Walgreens gets go-ahead to purchase hundreds of Rite Aid stores.

Adverse events after vaccinations don’t usually recur after reimmunizations.

First dose of HepB vaccine should be given in the first 24 hours to prevent infection.

A huge number of opioids go unused. So where do they go?

Rite Aid’s KidsCents will offer free flu shots to children.

Hospital pharmacists and physicians saved millions on cardiovascular meds.

The new machines will feature of variety of OTC meds and other products.

International pharmacy group says that pharmacists should create advance plans for major disasters.

In Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.

PBMs are evolving, but what will they be evolving into and will they be more transparent?

Neratinib (Nerlynx) is an extended adjuvant treatment for patients with early stage HER2 positive breast cancer who are receiving trastuzumab therapy.

Opioid limits are gaining popularity, but do they actually work?

Technology can help reduce error rates in IV compounding.

Ransomware and cybersecurity threats expose patients to risks.

It's no news that pharmacists are stressed, but how is it affecting job performance-and how do pharmacists cope?

Check out the latest changes to the Express Scripts formulary

How one day could help your patients manage their meds.

Not all drugs are incredible-and sometimes even the incredible ones have weird origins.

The FIP awards honored two international pharmacy associations for their recent campaigns.

Rivaroxaban (Xarelto, Janssen/ Bayer) has been found to significantly reduce the risk of strokes and heart attacks in patients with artery disease.

EpiPen manufacturer is accused of lax investigation into problems.

Education about anticoagulants helped boost adherence rates and led to a small decrease in stroke risk.

Sodium polystyrene sulfonate interferes with many oral drugs and should be dosed separately.

The use of health IT has exploded in the last decade, and that means better health care.

After trials halted, FDA issues warning on off-label use of the drug.

After Mylotarg was taken voluntarily taken off the market, the FDA is giving it a second chance.

The city's decision is the latest move against tobacco in pharmacies.

Mid Valley Pharmaceutical recalls two drugs.